Women with triple negative breast cancer will gain access to pembrolizumab after deal with its manufacturer
Women with a particularly aggressive form of breast cancer have been given access to a “potentially life-saving” drug after NHS bosses struck a deal with its manufacturer.
Up to 1,600 women a year will be able to get pembrolizumab, which has the potential to leave some of those who take it completely free of cancer, NHS England said.
